A new paper is out titled “Safety Considerations for Dietary Supplement Manufacturers in the United States", co-authored by Jay Sirois, PhD, VP of regulatory and scientific affairs, Consumer Healthcare Products Association, alongside several CHPA manufacturers in the Journal of Regulatory Toxicology and Pharmacology.
